Approval · Notice of Compliance 37923 · 2026
METVIX: Notice of Compliance 37923
Issued July 17, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37923
- Date
- July 17, 2026
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to Instructions for Use
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METVIX | Not yet assigned | — |
Medicinal ingredients
- METHYL AMINOLEVULINATE HYDROCHLORIDE 168 MG per G